These Products Saw Falling Sales in Pfizer’s Q2 2018
Pfizer’s (PFE) portfolio also includes a few products that are losing market share due to competition from other products in the market. These products include Enbrel (outside the United States and Canada), Sutent, Xalkori, BeneFix, Premarin Family, Medrol, Celebrex, Lyrica, and Viagra.